JP2006008568A - ＩｇＥ抗体抑制剤および食品 - Google Patents

ＩｇＥ抗体抑制剤および食品 Download PDF

Info

Publication number
JP2006008568A
JP2006008568A JP2004186898A JP2004186898A JP2006008568A JP 2006008568 A JP2006008568 A JP 2006008568A JP 2004186898 A JP2004186898 A JP 2004186898A JP 2004186898 A JP2004186898 A JP 2004186898A JP 2006008568 A JP2006008568 A JP 2006008568A
Authority
JP
Japan
Prior art keywords
ige antibody
food
cyclodextrin
antibody inhibitor
allergic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004186898A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006008568A5 (cg-RX-API-DMAC7.html
Inventor
Keiji Terao
啓二 寺尾
Iwao Tate
巌 舘
Daisuke Nakada
大介 中田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CycloChem Co Ltd
Original Assignee
CycloChem Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CycloChem Co Ltd filed Critical CycloChem Co Ltd
Priority to JP2004186898A priority Critical patent/JP2006008568A/ja
Priority to PCT/EP2005/006817 priority patent/WO2006000421A2/en
Publication of JP2006008568A publication Critical patent/JP2006008568A/ja
Publication of JP2006008568A5 publication Critical patent/JP2006008568A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
JP2004186898A 2004-06-24 2004-06-24 ＩｇＥ抗体抑制剤および食品 Pending JP2006008568A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2004186898A JP2006008568A (ja) 2004-06-24 2004-06-24 ＩｇＥ抗体抑制剤および食品
PCT/EP2005/006817 WO2006000421A2 (en) 2004-06-24 2005-06-23 Ige antibody repressing agent comprising alpha cyclodextrin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004186898A JP2006008568A (ja) 2004-06-24 2004-06-24 ＩｇＥ抗体抑制剤および食品

Publications (2)

Publication Number Publication Date
JP2006008568A true JP2006008568A (ja) 2006-01-12
JP2006008568A5 JP2006008568A5 (cg-RX-API-DMAC7.html) 2007-08-02

Family

ID=34979676

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004186898A Pending JP2006008568A (ja) 2004-06-24 2004-06-24 ＩｇＥ抗体抑制剤および食品

Country Status (2)

Country Link
JP (1) JP2006008568A (cg-RX-API-DMAC7.html)
WO (1) WO2006000421A2 (cg-RX-API-DMAC7.html)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008515847A (ja) * 2004-10-10 2008-05-15 ユニベルシテ・ド・リエージュ 気管支炎症性疾患の治療及び予防のためのシクロデキストリンの使用
JP2019507756A (ja) * 2016-02-28 2019-03-22 アルデイラ セラピューティクス， インコーポレイテッド シクロデキストリンを用いるアレルギーの眼の状態の処置
US11197821B2 (en) 2018-09-25 2021-12-14 Aldeyra Therapeutics, Inc. Formulations for treatment of dry eye disease
US11312692B1 (en) 2018-08-06 2022-04-26 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
US11724987B2 (en) 2005-05-26 2023-08-15 Aldeyra Therapeutics, Inc. Compositions and methods of treating retinal disease
US11786518B2 (en) 2019-03-26 2023-10-17 Aldeyra Therapeutics, Inc. Ophthalmic formulations and uses thereof
US12029735B2 (en) 2019-05-02 2024-07-09 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
US12064516B2 (en) 2020-05-13 2024-08-20 Aldeyra Therapeutics, Inc. Pharmaceutical formulations and uses thereof
US12098132B2 (en) 2019-05-02 2024-09-24 Aldeyra Therapeutics, Inc. Process for preparation of aldehyde scavenger and intermediates
US12097188B2 (en) 2009-12-11 2024-09-24 Aldeyra Therapeutics, Inc. Compositions and methods for the treatment of macular degeneration
US12128013B2 (en) 2013-01-23 2024-10-29 Aldeyra Therapeutics, Inc. Toxic aldehyde related diseases and treatment
US12240816B2 (en) 2015-08-21 2025-03-04 Aldeyra Therapeutics, Inc. Deuterated compounds and uses thereof

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012094703A1 (en) 2011-01-11 2012-07-19 Dimerix Bioscience Pty Ltd Combination therapy
MX387286B (es) 2015-09-29 2025-03-18 Kimberly Clark Co Composicion sinergica para el mantenimiento de un equilibrio saludable de la microflora.
MX2018013472A (es) 2016-05-09 2019-02-28 Aldeyra Therapeutics Inc Tratamiento de combinacion de trastornos y enfermedades inflamatorios oculares.
GB2574534B (en) 2017-02-28 2022-06-08 Kimberly Clark Co Synergistic composition for maintenance of healthy balance of microflora
EP3694500A4 (en) 2017-10-10 2021-06-30 Aldeyra Therapeutics, Inc. TREATMENT OF INFLAMMATORY DISORDERS
BE1027425B1 (fr) 2019-07-01 2021-02-08 Aquilon Pharmaceuticals Composition inhalable comprenant de la cyclodextrine a utiliser dans le traitement d’inflammations nasales
JPWO2021177248A1 (cg-RX-API-DMAC7.html) * 2020-03-02 2021-09-10

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54145268A (en) * 1978-05-04 1979-11-13 Tomoyasu Nakashima Beverage producing method
JPS62190121A (ja) * 1986-02-17 1987-08-20 Senjiyu Seiyaku Kk 水性液剤
JPH06153860A (ja) * 1992-11-25 1994-06-03 Nissei Kosan Kk 痩身用食品
JPH06225741A (ja) * 1993-02-02 1994-08-16 Kyokuto Internatl Corp 食品保存料及び食品の保存方法
JPH06239748A (ja) * 1992-12-25 1994-08-30 Senju Pharmaceut Co Ltd セチリジン含有抗アレルギー点眼点鼻用組成物
JPH07115935A (ja) * 1993-10-22 1995-05-09 Hairu:Kk 痩身用食品
JPH07115934A (ja) * 1993-10-22 1995-05-09 Hairu:Kk 痩身用食品
JPH08151332A (ja) * 1994-09-28 1996-06-11 Senju Pharmaceut Co Ltd 点鼻用水性懸濁液
JP2001220355A (ja) * 2000-02-07 2001-08-14 Teijin Ltd ＰＰＡＲβ／δ及びγリガンドからなる肥満細胞活性化抑制剤
JP2003055233A (ja) * 2001-08-06 2003-02-26 Nishikawa Rubber Co Ltd ＩｇＥ抗体抑制剤および食品
WO2003074483A1 (en) * 2002-03-05 2003-09-12 Ono Pharmaceutical Co., Ltd. 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0709099A3 (en) * 1994-09-28 1996-07-24 Senju Pharma Co Aqueous suspension for nasal administration containing cyclodextrin
WO1996014838A1 (en) * 1994-11-15 1996-05-23 Vivorx Pharmaceuticals, Inc. Novel diacetyldapsone-containing compositions and the use thereof for the treatment of various disease states
US6830758B2 (en) * 2001-04-02 2004-12-14 Lectec Corporation Psoriasis patch
EP1348714B1 (en) * 2002-03-25 2007-01-03 Council Of Scientific And Industrial Research Polypeptide useful as anti-allergic/antiasthmatic, methods for the preparation thereof and pharmaceutical compositions containing such polypeptide and their use
SE0303179D0 (sv) * 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54145268A (en) * 1978-05-04 1979-11-13 Tomoyasu Nakashima Beverage producing method
JPS62190121A (ja) * 1986-02-17 1987-08-20 Senjiyu Seiyaku Kk 水性液剤
JPH06153860A (ja) * 1992-11-25 1994-06-03 Nissei Kosan Kk 痩身用食品
JPH06239748A (ja) * 1992-12-25 1994-08-30 Senju Pharmaceut Co Ltd セチリジン含有抗アレルギー点眼点鼻用組成物
JPH06225741A (ja) * 1993-02-02 1994-08-16 Kyokuto Internatl Corp 食品保存料及び食品の保存方法
JPH07115935A (ja) * 1993-10-22 1995-05-09 Hairu:Kk 痩身用食品
JPH07115934A (ja) * 1993-10-22 1995-05-09 Hairu:Kk 痩身用食品
JPH08151332A (ja) * 1994-09-28 1996-06-11 Senju Pharmaceut Co Ltd 点鼻用水性懸濁液
JP2001220355A (ja) * 2000-02-07 2001-08-14 Teijin Ltd ＰＰＡＲβ／δ及びγリガンドからなる肥満細胞活性化抑制剤
JP2003055233A (ja) * 2001-08-06 2003-02-26 Nishikawa Rubber Co Ltd ＩｇＥ抗体抑制剤および食品
WO2003074483A1 (en) * 2002-03-05 2003-09-12 Ono Pharmaceutical Co., Ltd. 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008515847A (ja) * 2004-10-10 2008-05-15 ユニベルシテ・ド・リエージュ 気管支炎症性疾患の治療及び予防のためのシクロデキストリンの使用
US11724987B2 (en) 2005-05-26 2023-08-15 Aldeyra Therapeutics, Inc. Compositions and methods of treating retinal disease
US12097188B2 (en) 2009-12-11 2024-09-24 Aldeyra Therapeutics, Inc. Compositions and methods for the treatment of macular degeneration
US12128013B2 (en) 2013-01-23 2024-10-29 Aldeyra Therapeutics, Inc. Toxic aldehyde related diseases and treatment
US12240816B2 (en) 2015-08-21 2025-03-04 Aldeyra Therapeutics, Inc. Deuterated compounds and uses thereof
JP2019507756A (ja) * 2016-02-28 2019-03-22 アルデイラ セラピューティクス， インコーポレイテッド シクロデキストリンを用いるアレルギーの眼の状態の処置
JP7450242B2 (ja) 2016-02-28 2024-03-15 アルデイラ セラピューティクス， インコーポレイテッド シクロデキストリンを用いるアレルギーの眼の状態の処置
US11312692B1 (en) 2018-08-06 2022-04-26 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
US12006298B2 (en) 2018-08-06 2024-06-11 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
US11197821B2 (en) 2018-09-25 2021-12-14 Aldeyra Therapeutics, Inc. Formulations for treatment of dry eye disease
US11786518B2 (en) 2019-03-26 2023-10-17 Aldeyra Therapeutics, Inc. Ophthalmic formulations and uses thereof
US12029735B2 (en) 2019-05-02 2024-07-09 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
US12098132B2 (en) 2019-05-02 2024-09-24 Aldeyra Therapeutics, Inc. Process for preparation of aldehyde scavenger and intermediates
US12064516B2 (en) 2020-05-13 2024-08-20 Aldeyra Therapeutics, Inc. Pharmaceutical formulations and uses thereof

Also Published As

Publication number Publication date
WO2006000421A3 (en) 2006-04-13
WO2006000421A2 (en) 2006-01-05

Similar Documents

Publication Publication Date Title
US11213543B2 (en) Human gastrointestinal microbiome modulating composition and methods of use
JP2006008568A (ja) ＩｇＥ抗体抑制剤および食品
JP2009502958A (ja) ストレスの治療または管理の方法
JP4162147B2 (ja) アレルギー抑制剤
KR101065544B1 (ko) 밤 유래의 당질 분해 효소 저해 물질 및 그의 용도
JP6976030B2 (ja) 非アルコール性脂肪肝疾患の予防または改善用組成物
CN106028837B (zh) 使用肉桂醛和锌进行体重管理的方法和组合物
EP3761995A1 (en) Yeast beta glucans
TWI465245B (zh) Peptides with antidiabetic effect and their use
EP4125436A1 (en) Ulcerative colitis diet, formulae, products and methods thereof
Calbom et al. Coconut Diet: The Secret Ingredient That Helps You Lose Weight While You Eat Your Favorite Foods
JP2012162472A (ja) 脂質排泄促進剤
JP2008156264A (ja) ルイボスティーの食後高血糖および血中尿酸低下作用
JP7761397B2 (ja) Ｑｏｌ改善剤、ｑｏｌ改善用食品組成物、又はｑｏｌ改善用医薬組成物
US11328621B2 (en) Dietary regime for treatment of acne and other inflammatory skin conditions
JP2018058770A (ja) スジアオノリの新規用途
JP2007137803A (ja) 血管内皮機能改善組成物
JP2024051403A (ja) ｐＩｇＲ発現促進用組成物
Awasthi et al. Renal Calculi-Prevalence, Risk Factors and Dietary Management: A Review
Lessof Clinical Manifestations
KR20210012164A (ko) 니클로사마이드 및 디옥타헤드랄 스멕타이트를 포함하는 염증성 장 질환 예방 및 치료용 조성물
JP2021084859A (ja) ダイエットの方法
KEMP DIET IN DISEASES OF THE INTESTINAL TRACT
KR20150071279A (ko) 김치의 동결건조 분말을 함유하는 대장염 예방 및 치료용 조성물
JP2014501516A (ja) 酸化物および／または水酸化物を含んでなる食品組成物および食料製品の新たな使用

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070615

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070615

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101026

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110322